Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Feb;41(2):630-636.
doi: 10.12669/pjms.41.2.10729.

Impact of non-alcoholic fatty liver disease and liver fibrosis on outcomes of acute ischemic stroke: A systematic review and meta-analysis

Liting Yang  1 , Jian Han  2 , Chenghui Qin  3 , Feifeng Song  4
Affiliations
Review

Impact of non-alcoholic fatty liver disease and liver fibrosis on outcomes of acute ischemic stroke: A systematic review and meta-analysis

Liting Yang et al. Pak J Med Sci. 2025 Feb.

Abstract

Objective: We reviewed the evidence on the impact of non-alcoholic fatty liver disease (NAFLD) and liver fibrosis on mortality, functional dependence, and recurrence after acute ischemic stroke (AIS).

Methods: This PROSPERO registered review searched PubMed, Embase, CENTRAL, and Web of Science databases from inception of databases to 30th July 2023 for studies comparing outcomes of AIS based on the presence of NAFLD and liver fibrosis. Adjusted data on mortality, functional dependence and risk of recurrent AIS was pooled to obtain odds ratio (OR) with 95% confidence intervals (CI) in a random-effects model.

Results: Ten studies were included. Descriptive analysis showed conflicting effects of NAFLD on AIS outcomes with some studies showing better functional outcomes with the presence of NAFLD. Meta-analysis showed that the presence of liver fibrosis was associated with a significantly increased risk of mortality (OR: 2.22 95% CI: 1.02-4.86 I2=92%) and functional dependence (OR: 1.89 95% CI: 1.27-2.82 I2=53%) as compared to no fibrosis. Meta-analysis found that liver fibrosis did not increase the risk of recurrent AIS (OR: 1.32 95% CI: 0.74-2.37 I2=74%).

Conclusion: Scant evidence exists for the effect of NAFLD and liver fibrosis on AIS outcomes. A paradoxical effect of NAFLD on functional outcomes has been noted which needs confirmation by future studies. Liver fibrosis was found to increase the risk of mortality and functional dependence in AIS.

Keywords: Liver steatosis; Mortality; Steatohepatitis; Stroke.

PubMed Disclaimer

Figures

Fig.1
Fig.1
Study flowchart.
Fig.2
Fig.2
Meta-analysis of risk of mortality after AIS based on the presence of liver fibrosis.
Fig.3
Fig.3
Meta-analysis of risk of functional dependence after AIS based on the presence of liver fibrosis.
Fig.4
Fig.4
Meta-analysis of risk of recurrence after AIS based on the presence of liver fibrosis.
See this image and copyright information in PMC

References

    1. Campos-Murguía A, Ruiz-Margáin A, González-Regueiro JA, Macías-Rodríguez RU. Clinical assessment and management of liver fibrosis in non-alcoholic fatty liver disease. World J Gastroenterol. 2020;26:5919–5943. doi:10.3748/WJG. V26. I39.5919. - PMC - PubMed
    1. Younossi ZM, Golabi P, de Avila L, Paik JM, Srishord M, Fukui N, et al. The global epidemiology of NAFLD and NASH in patients with Type-2 diabetes:A systematic review and meta-analysis. J Hepatol. 2019;71:793–801. doi:10.1016/J. JHEP.2019.06.021. - PubMed
    1. Gofton C, Upendran Y, Zheng MH, George J. MAFLD:How is it different from NAFLD? Clin Mol Hepatol. 2023;29(Suppl):S17. doi:10.3350/CMH.2022.0367. - PMC - PubMed
    1. Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41:1313–1321. doi:10.1002/HEP.20701. - PubMed
    1. Dulai PS, Singh S, Patel J, Soni M, Prokop LJ, Younossi Z, et al. Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease:Systematic review and meta-analysis. Hepatology. 2017;65:1557–1565. doi:10.1002/HEP.29085. - PMC - PubMed